TRANSCODE THERAPEUTICS INC (RNAZ)

US89357L3033 - Common Stock

1.15  +0.27 (+29.97%)

After market: 1.17 +0.02 (+1.74%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

 2023
(2023-12-31)		 2022
(2022-12-31)		 2021
(2021-12-31)		 2020
(2020-12-31)		 2019
(2019-12-31)
ASSETS
Current Assets
Cash
N/A10.00KN/AN/AN/A
Cash Equivalents
2.77M4.97M20.83M830.00K200.00K
Receivables
N/A360.00KN/AN/AN/A
Other Current Assets
1.69M2.04M1.91M0.000.00
Total Current Assets
4.46M7.38M22.73M830.00K200.00K
 
Non-Current Assets
PPE Net
602.40K210.00K210.00KN/AN/A
Other Non-Current Assets
111.86KN/A0.00220.00K0.00
Total Non-Current Assets
714.26K210.00K210.00K230.00K0.00
 
TOTAL ASSETS
5.17M7.59M22.94M1.06M200.00K
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accrued Expenses
1.51M920.00KN/AN/AN/A
Accounts Payable
1.96M3.42M2.50M370.00K30.00K
Other Current Liabilities
27.06K0.0030.00K40.00K40.00K
Total Current Liabilities
3.49M4.35M2.53M400.00K60.00K
 
Non-Current Liabilities
Long Term Debt
0.000.000.002.09M930.00K
Other Non-Current Liabilities
38.29KN/A0.001.97M320.00K
Total Non-Current Liabilities
38.29K0.000.004.06M1.25M
 
TOTAL LIABILITIES
3.53M4.35M2.53M4.46M1.31M
 
SHAREHOLDERS' EQUITY
Retained Earnings
-46.42M-27.87M-10.31M-3.46M-1.12M
Additional Paid In Capital
48.06M31.11M30.71M50.00K10.00K
Common Shares
60.000.000.000.000.00
Shares Outstanding
627.45K650.00K650.00K420.00K420.00K
Tangible Book Value per Share
2.624.9831.38-8.12-2.64
Total Shareholders' Equity
1.64M3.24M20.40M-3.41M-1.11M
 
TOTAL LIABILITIES AND EQUITY
5.17M7.59M22.94M1.06M200.00K
 
Statistics
Debt/Equity
N/AN/AN/A-0.61-0.84
Current Ratio
1.281.708.982.083.33
Return On Assets (ROA)
-358.75%-231.36%-29.82%-220.75%-305.00%
Return On Equity (ROE)
-1130.30%-541.98%-33.53%N/AN/A

All data in USD

Charts